Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 06, 2021 04:00 ET | Source: AKAMPION

Adept Neuro Reaches Key Milestone in the Development of Novel Intracerebral Stereoelectroencephalography (SEEG) Electrodes

Second investment tranche provided by DIXI medicalPreparation of regulatory certifications and market launch Adept Neuro SA (Lausanne, Switzerland), a joint venture of DIXI Medical (Le Locle,...
June 17, 2021 03:00 ET | Source: AKAMPION

Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional Deep Brain Stimulation System

- First system implanted at University Hospital of Dresden / Prof. Sobottka - Post-market clinical follow-up and revenue-generating study in the EU - Targeting US FDA IDE approval in Q4, 2021 ...
June 16, 2021 14:00 ET | Source: AKAMPION

Science Translational Medicine Publication: Innovative Molecules´ Drug Candidate Affects Recurrent Herpes Simplex Virus Infections

- IM-250 reduces viral load, viral shedding and recurrence rate - Potential treatment for persistent, neurotrophic herpes simplex Munich, Germany, June 16, 2021 - Innovative Molecules GmbH, a drug...
June 07, 2021 04:00 ET | Source: AKAMPION

Innovative Molecules raises €20 million Series A equity financing round

- Proceeds dedicated to advance Herpes simplex treatment IM-250 to Phase II - IM-250 demonstrates unprecedented impact on viral reservoir in preclinical studies Munich, Germany, June 7, 2021 -...
May 18, 2021 03:30 ET | Source: AKAMPION

MerLion Pharmaceuticals Completes Growth Financing Round

- Proceeds will be used to facilitate MerLion`s production and market launch of XtoroTM Berlin, (18/05/2021) - MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research...
April 12, 2021 03:45 ET | Source: AKAMPION

ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel Therapeutic Antibody to Treat Inflammatory Rheumatic Diseases

- Company forms international consortium with ProteoGenix SAS and Amsterdam UMC Schlieren (Zurich Area), Switzerland – April 12, 2021 – ImmunOs Therapeutics AG, a Swiss bio-technology company...
April 07, 2021 06:00 ET | Source: AKAMPION

T-knife Therapeutics Announces the Appointment of Donald Wuchterl as Senior Vice President and Chief Manufacturing Officer

San Francisco, CA / Berlin, Germany – April 7, 2021 — T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing innovative therapeutics for the benefit of solid tumor patients...
February 22, 2021 04:00 ET | Source: AKAMPION

SEQ-IT vermeldet Durchbruch in der schnellen Variantendiagnostik von SARS-CoV-2

Kaiserslautern, Deutschland, 22. Februar 2021 – SEQ-IT, ein führender Anbieter von molekularen Dienstleistungen, gibt die Entwicklung eines neuartigen Massenspektrometrie-basierten Tests für den...
February 22, 2021 04:00 ET | Source: AKAMPION

SEQ-IT reports breakthrough in the rapid variant diagnosis of SARS-CoV-2

Kaiserslautern, Germany, February 22, 2021 – SEQ-IT, a leading molecular services provider, today announced they completed a novel mass spectrometry based rapid test for the detection of 20 of the...
January 19, 2021 06:00 ET | Source: AKAMPION

T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer

San Francisco, CA / Berlin, Germany – January 19, 2021 — T-knife GmbH, a next-generation adoptive T-cell therapy company leveraging its proprietary humanized T-cell receptor (HuTCR) mouse platform to...